0000899243-19-017621.txt : 20190620 0000899243-19-017621.hdr.sgml : 20190620 20190620160528 ACCESSION NUMBER: 0000899243-19-017621 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190618 FILED AS OF DATE: 20190620 DATE AS OF CHANGE: 20190620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Viret Jean-Frederic CENTRAL INDEX KEY: 0001427569 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 19908600 MAIL ADDRESS: STREET 1: ANESIVA, INC. STREET 2: 650 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-18 0 0001512762 Coherus BioSciences, Inc. CHRS 0001427569 Viret Jean-Frederic COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 0 1 0 0 Chief Financial Officer Common Stock, $0.0001 par value 2019-06-18 4 S 0 3000 19.3088 D 12180 D Common Stock, $0.0001 par value 2019-06-19 4 S 0 667 20.00 D 11513 D Common Stock, $0.0001 par value 2019-06-19 4 M 0 3159 10.05 A 14672 D Common Stock, $0.0001 par value 2019-06-19 4 S 0 3059 20.3224 D 11613 D Common Stock, $0.0001 par value 2019-06-19 4 S 0 100 20.81 D 11513 D Stock Option (Right to Buy) 10.05 2019-06-19 4 M 0 3159 0.00 D 2028-02-01 Common Stock 3159 126841 D The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person. The transaction was executed in multiple trades in prices ranging from $19.04 to $19.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Includes 1,995 shares acquired on May 15, 2019 pursuant to Issuer's employee stock purchase plan. The transaction was executed in multiple trades in prices ranging from $19.75 to $20.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Jean-Frederic Viret 2019-06-20